Assignee
KNC LABORATORIES CO LTD
JP·3 granted patents·3 pending applications·0 citations·filing 2015–2022
Top patents by PatentIndex Score
6 records- 0151US2024229036A9Nucleic acid medicine expressing splicing variant of myostatinKNC LABORATORIES CO LTD·Filed 2022·Application pending·0 cites
- 0249US12202869B2Inhibition of myostatin signal by myostatin splice variant-derived protein and utilization thereofKNC LABORATORIES CO LTD·Filed 2020·Granted Jan 21, 2025·0 cites·6 claims
- 0349US2023272403A1Antisense oligonucleotide inducing exon skipping of angiotensin converting enzyme 2 geneKNC LABORATORIES CO LTD·Filed 2021·Application pending·0 cites
- 0441US2022220478A1Nucleic acid drug suppressing production of myostatin gene mrnaKNC LABORATORIES CO LTD·Filed 2020·Application pending·0 cites
- 0538US10174319B2Nucleic acid drug for inducing skipping of variant exon of CD44 gene and increasing expression of normal type CD44 mRNAKNC LABORATORIES CO LTD·Filed 2015·Granted Jan 8, 2019·0 cites·13 claims
- 0637US11891412B2Production of highly fat-soluble phosphoramiditeKNC LABORATORIES CO LTD·Filed 2018·Granted Feb 6, 2024·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when KNC LABORATORIES CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →